SOW
ENTA icon

State of Wyoming’s Enanta Pharmaceuticals ENTA Stock Holding History

State of Wyoming’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.73K Sell
530
-12,943
-96% -$174K ﹤0.01% 1836
2026
Q1 		$170K Sell
13,473
-19,414
-59% -$260K 0.02% 1050
2025
Q4 		$519K Buy
+32,887
New +$418K 0.06% 349

Other funds holding ENTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

State of Wyoming's ENTA Position: Q2 2026 in Review

State of Wyoming reduced its Enanta Pharmaceuticals (ENTA) stake by 96% in Q2 2026, selling an estimated $174K and leaving 530 shares worth $7.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1836.

State of Wyoming first reported a position in ENTA in Q4 2025 and has held it in 3 quarters since. The position peaked at $519K in Q4 2025. 49 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • State of Wyoming held 530 shares of Enanta Pharmaceuticals worth $7.73K as of Q2 2026.
  • State of Wyoming sold 12,943 Enanta Pharmaceuticals shares in Q2 2026, an estimated $174K.
  • Enanta Pharmaceuticals made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1836 holding.
  • State of Wyoming first reported a position in Enanta Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • State of Wyoming's Enanta Pharmaceuticals position peaked at $519K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.